Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Journal of the American College of Cardiology
|
February 16, 2018
Risk Scores-Medical Derivatives
Ronald S Freudenberger
The Annals of Pharmacotherapy
|
January 27, 2004
Ephedra-associated cardiomyopathy
Sarjita D Naik, Ronald S Freudenberger
Current Heart Failure Reports
|
May 25, 2007
Beta-blocker contraindications: are there patients or situations where use is inappropriate?
S D Naik, Ronald S Freudenberger
Current Opinion in Critical Care
|
September 26, 2003
Is there an optimal hemoglobin value in the cardiac intensive care unit?
Ronald S Freudenberger, Jeffrey L Carson
Journal of Cardiac Failure
|
October 4, 2005
Silent cerebral infarction in heart failure: vascular or thromboembolic?
Ronald S Freudenberger, Barry M Massie
Nature Clinical Practice. Cardiovascular Medicine
|
October 26, 2006
Should we use anticoagulation for patients with chronic heart failure?
Ronald S Freudenberger, Jonathan L Halperin
Current Opinion in Cardiology
|
April 3, 2008
What do we know about anticoagulation in patients with heart failure?
Amy M Ahnert, Ronald S Freudenberger
Thrombosis and Haemostasis
|
December 22, 2009
What is the appropriate approach to prevention of thromboembolism in heart failure?
Ronald S Freudenberger, Matthew M Schumaecker, Shunichi Homma
The American Journal of Cardiology
|
July 17, 2007
Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study)
Ronald S Freudenberger, Alan C Wilson, John B Kostis, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
September 16, 2004
Policies of U.S. heart transplant programs regarding transplantation of human immunodeficiency-positive patients
Ronald S Freudenberger, Susan E Boruchoff, Mark B Anderson
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Journal of the American College of Cardiology
|
February 16, 2018
Risk Scores-Medical Derivatives
Ronald S Freudenberger
The Annals of Pharmacotherapy
|
January 27, 2004
Ephedra-associated cardiomyopathy
Sarjita D Naik, Ronald S Freudenberger
Current Heart Failure Reports
|
May 25, 2007
Beta-blocker contraindications: are there patients or situations where use is inappropriate?
S D Naik, Ronald S Freudenberger
Current Opinion in Critical Care
|
September 26, 2003
Is there an optimal hemoglobin value in the cardiac intensive care unit?
Ronald S Freudenberger, Jeffrey L Carson
Journal of Cardiac Failure
|
October 4, 2005
Silent cerebral infarction in heart failure: vascular or thromboembolic?
Ronald S Freudenberger, Barry M Massie
Nature Clinical Practice. Cardiovascular Medicine
|
October 26, 2006
Should we use anticoagulation for patients with chronic heart failure?
Ronald S Freudenberger, Jonathan L Halperin
Current Opinion in Cardiology
|
April 3, 2008
What do we know about anticoagulation in patients with heart failure?
Amy M Ahnert, Ronald S Freudenberger
Thrombosis and Haemostasis
|
December 22, 2009
What is the appropriate approach to prevention of thromboembolism in heart failure?
Ronald S Freudenberger, Matthew M Schumaecker, Shunichi Homma
The American Journal of Cardiology
|
July 17, 2007
Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study)
Ronald S Freudenberger, Alan C Wilson, John B Kostis, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
September 16, 2004
Policies of U.S. heart transplant programs regarding transplantation of human immunodeficiency-positive patients
Ronald S Freudenberger, Susan E Boruchoff, Mark B Anderson
Page
of 4